Gastroenterology

 
FIT Tests, Direct Mailed, Increase Initiation of CRC Screening in Adults Aged 45 to 49
August 05, 2025

For initiating colorectal cancer screening in average-risk young adults, a default mailed outreach strategy outperformed 3 active choice options in a randomized study.

Fecal Microbiota Transplant Found Noninferior to Antibiotic as Initial Treatment for C. Diff
June 17, 2025

Using FMT over standard-of-care therapy may significantly reduce antibiotic use and well-known harms, including antibiotic resistance, study authors noted.

Real-World Study Confirms Upadacitinib’s Efficacy in Crohn Disease Treatment: Daily Dose
May 29, 2025

Your daily dose of the clinical news you may have missed.

Fecal Microbiota Treatment via Colonoscopy Safe, Effective for Recurrent C. Diff, Study Suggests
May 05, 2025

DDW 2025. Colonoscopic delivery of fecal therapy prevented recurrent C. diff infection in 95% of participants for 8 weeks, with mild GI adverse events reported by

Upadacitinib Found Effective in Achieving Remission in Crohn Disease, Including Biologic-Experienced Patients
April 25, 2025

Upadacitinib shows promising real-world effectiveness for managing moderate-to-severe Crohn disease, even in patients with prior treatment exposure.

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose
April 08, 2025

Your daily dose of the clinical news you may have missed.

Guselkumab (Tremfya) Wins Approval for Crohn Disease, Fourth Indication for Immune-Mediated Diseases
March 21, 2025

The IL-23 inhibitor is the only drug in the class available with both subcutaneous and intravenous administration options for treatment induction, according to J&J.

Dupilumab Shows Efficacy in Eosinophilic Esophagitis Regardless of Food Elimination Diets
March 04, 2025

The impact of food elimination diets on medication previously was unknown, according to new research presented at AAAAI 2025.

FDA Approves AbbVie's Combination Antibiotic Emblaveo for Complicated Intra-Abdominal Infections
February 07, 2025

The novel therapy combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children
January 27, 2025

Researchers at Phoenix Children’s Hospital conducted one of the largest real-world clinical evaluations of the esophageal string test in children.